-DOCSTART- -X- O
BACKGROUND -X- _ O
: -X- _ O
The -X- _ O
emerging -X- _ O
avian -X- _ O
influenza -X- _ O
A -X- _ O
( -X- _ O
H7N9 -X- _ O
) -X- _ O
virus -X- _ O
, -X- _ O
a -X- _ O
subtype -X- _ O
of -X- _ O
influenza -X- _ O
viruses -X- _ O
, -X- _ O
was -X- _ O
first -X- _ O
discovered -X- _ O
in -X- _ O
March -X- _ O
2013 -X- _ O
in -X- _ O
China. -X- _ O
Infected -X- _ O
patients -X- _ O
frequently -X- _ O
present -X- _ O
with -X- _ O
pneumonia -X- _ O
and -X- _ O
acute -X- _ O
respiratory -X- _ O
disorder -X- _ O
syndrome -X- _ O
with -X- _ O
high -X- _ O
rates -X- _ O
of -X- _ O
intensive -X- _ O
care -X- _ O
unit -X- _ O
admission -X- _ O
and -X- _ O
death. -X- _ O
Neurological -X- _ O
complications -X- _ O
, -X- _ O
such -X- _ O
as -X- _ O
Guillain–Barré -X- _ O
syndrome -X- _ O
( -X- _ O
GBS -X- _ O
) -X- _ O
, -X- _ O
and -X- _ O
intensive -X- _ O
care -X- _ O
unit-acquired -X- _ O
weakness -X- _ O
, -X- _ O
including -X- _ O
critical -X- _ O
illness -X- _ O
polyneuropathy -X- _ O
and -X- _ O
myopathy -X- _ O
, -X- _ O
have -X- _ O
only -X- _ O
rarely -X- _ O
been -X- _ O
reported -X- _ O
previously. -X- _ O
CASE -X- _ O
PRESENTATION -X- _ O
: -X- _ O
In -X- _ O
this -X- _ O
study -X- _ O
, -X- _ O
we -X- _ O
report -X- _ O
on -X- _ O
two -X- _ O
Chinese -X- _ O
patients -X- _ O
with -X- _ O
H7N9 -X- _ O
severe -X- _ O
pneumonia -X- _ O
presenting -X- _ O
neurological -X- _ O
complications. -X- _ O
These -X- _ O
two -X- _ O
patients -X- _ O
had -X- _ O
non-immune -X- _ B-Comparison
diseases -X- _ I-Comparison
prior -X- _ I-Comparison
to -X- _ I-Comparison
the -X- _ I-Comparison
onset -X- _ I-Comparison
of -X- _ I-Comparison
virus -X- _ I-Comparison
infection. -X- _ I-Comparison
A -X- _ O
56-year-old -X- _ B-Patient
female -X- _ I-Patient
patient -X- _ I-Patient
( -X- _ I-Patient
case -X- _ I-Patient
1 -X- _ I-Patient
) -X- _ I-Patient
and -X- _ I-Patient
a -X- _ I-Patient
78-year-old -X- _ I-Patient
female -X- _ I-Patient
patient -X- _ I-Patient
( -X- _ I-Patient
case -X- _ I-Patient
2 -X- _ I-Patient
) -X- _ I-Patient
were -X- _ O
admitted -X- _ O
because -X- _ O
of -X- _ O
fever -X- _ O
, -X- _ O
cough -X- _ O
, -X- _ O
chest -X- _ O
tightness -X- _ O
and -X- _ O
shortness -X- _ O
of -X- _ O
breath. -X- _ O
These -X- _ O
patients -X- _ O
were -X- _ O
confirmed -X- _ O
to -X- _ O
have -X- _ O
H7N9 -X- _ B-Intervention
infection -X- _ I-Intervention
soon -X- _ I-Intervention
after -X- _ I-Intervention
admission -X- _ I-Intervention
followed -X- _ I-Intervention
by -X- _ I-Intervention
the -X- _ I-Intervention
development -X- _ I-Intervention
of -X- _ I-Intervention
acute -X- _ I-Intervention
respiratory -X- _ I-Intervention
distress -X- _ I-Intervention
syndrome -X- _ I-Intervention
and -X- _ I-Intervention
various -X- _ I-Intervention
severe -X- _ I-Intervention
bacterial -X- _ I-Intervention
and -X- _ I-Intervention
fungal -X- _ I-Intervention
infections. -X- _ I-Intervention
The -X- _ O
case -X- _ O
1 -X- _ O
patient -X- _ O
was -X- _ O
found -X- _ O
to -X- _ O
have -X- _ O
muscle -X- _ O
weakness -X- _ O
in -X- _ O
all -X- _ O
extremities -X- _ O
after -X- _ O
withdrawing -X- _ O
the -X- _ O
mechanical -X- _ O
ventilator -X- _ O
, -X- _ O
and -X- _ O
the -X- _ O
case -X- _ O
2 -X- _ O
patient -X- _ O
was -X- _ O
found -X- _ O
when -X- _ O
withdrawing -X- _ O
extracorporeal -X- _ O
membrane -X- _ O
oxygenation -X- _ O
, -X- _ O
both -X- _ O
of -X- _ O
these -X- _ O
conditions -X- _ O
prolonged -X- _ O
ventilator-weaning -X- _ O
time. -X- _ O
Furthermore -X- _ O
, -X- _ O
the -X- _ O
case -X- _ O
1 -X- _ O
patient -X- _ O
carried -X- _ O
the -X- _ O
H7N9 -X- _ O
virus -X- _ O
for -X- _ O
a -X- _ O
prolonged -X- _ O
period -X- _ O
, -X- _ O
reaching -X- _ O
28 -X- _ O
days -X- _ O
, -X- _ O
and -X- _ O
both -X- _ O
of -X- _ O
them -X- _ O
stayed -X- _ O
in -X- _ O
the -X- _ O
hospital -X- _ O
for -X- _ O
more -X- _ O
than -X- _ O
two -X- _ O
months. -X- _ O
A -X- _ O
clinical -X- _ B-Outcome
diagnosis -X- _ I-Outcome
of -X- _ I-Outcome
intensive -X- _ I-Outcome
care -X- _ I-Outcome
unit-acquired -X- _ I-Outcome
weakness -X- _ I-Outcome
could -X- _ I-Outcome
be -X- _ I-Outcome
confirmed. -X- _ I-Outcome
However -X- _ O
, -X- _ O
based -X- _ O
on -X- _ O
results -X- _ O
from -X- _ O
electrophysiological -X- _ O
testing -X- _ O
and -X- _ O
needle -X- _ O
electromyography -X- _ O
of -X- _ O
these -X- _ O
2 -X- _ O
patients -X- _ O
, -X- _ O
it -X- _ O
is -X- _ O
difficult -X- _ O
to -X- _ O
differentiate -X- _ O
critical -X- _ O
illness -X- _ O
polyneuropathy -X- _ O
from -X- _ O
GBS -X- _ O
, -X- _ O
since -X- _ O
no -X- _ O
lumbar -X- _ O
puncture -X- _ O
or -X- _ O
muscle -X- _ O
and -X- _ O
nerve -X- _ O
biopsy -X- _ O
were -X- _ O
conducted -X- _ O
during -X- _ O
hospitalization. -X- _ O
Following -X- _ O
a -X- _ O
long-term -X- _ O
comprehensive -X- _ O
treatment -X- _ O
, -X- _ O
the -X- _ O
patients’ -X- _ O
neurological -X- _ O
condition -X- _ O
improved -X- _ O
gradually. -X- _ O
CONCLUSIONS -X- _ O
: -X- _ O
Although -X- _ O
there -X- _ O
is -X- _ O
great -X- _ O
improvement -X- _ O
in -X- _ O
saving -X- _ O
severe -X- _ O
patients’ -X- _ O
lives -X- _ O
from -X- _ O
fatal -X- _ O
respiratory -X- _ O
and -X- _ O
blood -X- _ O
infections -X- _ O
, -X- _ O
it -X- _ O
is -X- _ O
necessary -X- _ O
to -X- _ O
pay -X- _ O
sufficient -X- _ O
attention -X- _ O
and -X- _ O
to -X- _ O
use -X- _ O
more -X- _ O
methods -X- _ O
to -X- _ O
differentiate -X- _ O
GBS -X- _ O
from -X- _ O
intensive -X- _ O
care -X- _ O
unit-acquired -X- _ O
weakness. -X- _ O
This -X- _ O
unusual -X- _ O
neurological -X- _ O
complication -X- _ O
could -X- _ O
result -X- _ O
in -X- _ O
additional -X- _ O
complications -X- _ O
including -X- _ O
ventilator -X- _ O
associated -X- _ O
pneumonia -X- _ O
, -X- _ O
prolonged -X- _ O
hospital -X- _ O
stay -X- _ O
and -X- _ O
then -X- _ O
would -X- _ O
further -X- _ O
increase -X- _ O
the -X- _ O
death -X- _ O
rate -X- _ O
, -X- _ O
and -X- _ O
huge -X- _ O
costs -X- _ O
. -X- _ O

